148 related articles for article (PubMed ID: 19444873)
1. Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice.
Zhao H; Przybylska M; Wu IH; Zhang J; Maniatis P; Pacheco J; Piepenhagen P; Copeland D; Arbeeny C; Shayman JA; Aerts JM; Jiang C; Cheng SH; Yew NS
Hepatology; 2009 Jul; 50(1):85-93. PubMed ID: 19444873
[TBL] [Abstract][Full Text] [Related]
2. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M
Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235
[TBL] [Abstract][Full Text] [Related]
3. Increased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthase.
Yew NS; Zhao H; Hong EG; Wu IH; Przybylska M; Siegel C; Shayman JA; Arbeeny CM; Kim JK; Jiang C; Cheng SH
PLoS One; 2010 Jun; 5(6):e11239. PubMed ID: 20574539
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes.
Zhao H; Przybylska M; Wu IH; Zhang J; Siegel C; Komarnitsky S; Yew NS; Cheng SH
Diabetes; 2007 May; 56(5):1210-8. PubMed ID: 17470562
[TBL] [Abstract][Full Text] [Related]
5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
6. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
8. Reducing glycosphingolipid biosynthesis in airway cells partially ameliorates disease manifestations in a mouse model of asthma.
Karman J; Tedstone JL; Gumlaw NK; Zhu Y; Yew N; Siegel C; Guo S; Siwkowski A; Ruzek M; Jiang C; Cheng SH
Int Immunol; 2010 Jul; 22(7):593-603. PubMed ID: 20497953
[TBL] [Abstract][Full Text] [Related]
9. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
[TBL] [Abstract][Full Text] [Related]
10. Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism.
Lombardo E; van Roomen CP; van Puijvelde GH; Ottenhoff R; van Eijk M; Aten J; Kuiper J; Overkleeft HS; Groen AK; Verhoeven AJ; Aerts JM; Bietrix F
PLoS One; 2012; 7(10):e38520. PubMed ID: 23056165
[TBL] [Abstract][Full Text] [Related]
11. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
Takahashi N; Qi Y; Patel HR; Ahima RS
J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
[TBL] [Abstract][Full Text] [Related]
12. Hepatic glycosphingolipid deficiency and liver function in mice.
Jennemann R; Rothermel U; Wang S; Sandhoff R; Kaden S; Out R; van Berkel TJ; Aerts JM; Ghauharali K; Sticht C; Gröne HJ
Hepatology; 2010 May; 51(5):1799-809. PubMed ID: 20432257
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
14. Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice.
Singhal NS; Patel RT; Qi Y; Lee YS; Ahima RS
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E331-8. PubMed ID: 18505833
[TBL] [Abstract][Full Text] [Related]
15. Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice.
Laiglesia LM; Lorente-Cebrián S; Martínez-Fernández L; Sáinz N; Prieto-Hontoria PL; Burrell MA; Rodríguez-Ortigosa CM; Martínez JA; Moreno-Aliaga MJ
Int J Obes (Lond); 2018 Mar; 42(3):572-579. PubMed ID: 28895586
[TBL] [Abstract][Full Text] [Related]
16. Exposure to an environmentally relevant mixture of organochlorine compounds and polychlorinated biphenyls Promotes hepatic steatosis in male Ob/Ob mice.
Mulligan C; Kondakala S; Yang EJ; Stokes JV; Stewart JA; Kaplan BL; Howell GE
Environ Toxicol; 2017 Apr; 32(4):1399-1411. PubMed ID: 27533883
[TBL] [Abstract][Full Text] [Related]
17. Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.
Sheng X; Wang M; Lu M; Xi B; Sheng H; Zang YQ
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E886-93. PubMed ID: 21364120
[TBL] [Abstract][Full Text] [Related]
18. Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model.
Fang X; Du Z; Duan C; Zhan S; Wang T; Zhu M; Shi J; Meng J; Zhang X; Yang M; Zuo Y
Life Sci; 2021 Apr; 270():118966. PubMed ID: 33482185
[TBL] [Abstract][Full Text] [Related]
19. Effects of bile acid sequestration on hepatic steatosis in obese mice.
Solís N; Pizarro M; Quintero P; Arab JP; Riquelme A; Padilla O; Carrasco G; Pirola CJ; Sookoian S; Arrese M
Ann Hepatol; 2013 Jan-2014 Feb; 13(1):105-12. PubMed ID: 24378273
[TBL] [Abstract][Full Text] [Related]
20. Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice.
Jouihan H; Will S; Guionaud S; Boland ML; Oldham S; Ravn P; Celeste A; Trevaskis JL
Mol Metab; 2017 Nov; 6(11):1360-1370. PubMed ID: 29107284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]